Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 8 de 8
Filtrer
1.
Sci Adv ; 10(8): eadi8136, 2024 Feb 23.
Article de Anglais | MEDLINE | ID: mdl-38381821

RÉSUMÉ

Plastics are a recent particulate material in Earth's history. Because of plastics persistence and wide-range presence, it has a great potential of being a global age marker and correlation tool between sedimentary profiles. In this research, we query whether microplastics can be considered among the array of proxies to delimit the Anthropocene Epoch (starting from the year 1950 and above). We present a study of microplastics deposition history inferred from sediment profiles of lakes in northeastern Europe. The sediments were dated with independent proxies from the present back to the first half of the 18th century. Regardless of the sediment layer age, microplastic particles were found throughout the cores in all sites. Depending on particles' aspect ratio, less elongated particles were found deeper, while more elongated particles and fibers have reduced mobility. We conclude that interpretation of microplastics distribution in the studied sediment profiles is ambiguous and does not strictly indicate the beginning of the Anthropocene Epoch.

2.
Data Brief ; 47: 108992, 2023 Apr.
Article de Anglais | MEDLINE | ID: mdl-36879613

RÉSUMÉ

The dataset provides information on spectroscopically verified microplastics, both particles and fibers, from 44 marine surface water samples of two Baltic Sea sub-basins - the semi-enclosed Gulf of Riga and the Eastern Gotland Basin. Sampling was performed by using Manta trawl with a mesh size of 300 µm. Thereafter, the organic material was digested with sodium hydroxide, hydrogen peroxide and enzymes. Samples were filtered on glass fiber filters and analyzed visually, registering the shape, size, and color of each item. Where feasible, the polymer type was determined using Attenuated Total Reflection Fourier Transform Infrared (ATR-FTIR) spectroscopy method. The number of plastic particles per m3 of filtered water was determined. The data presented in this article may be useful for further research on microplastic pollution, meta-analysis and calculation of microplastic flow. Interpretation and analysis of total acquired data on micro debris and microplastics are reported in the article "Occurrence and spatial distribution of microplastics in the surface waters of the Baltic Sea and the Gulf of Riga".

3.
Eur J Pediatr ; 182(6): 2471-2483, 2023 Jun.
Article de Anglais | MEDLINE | ID: mdl-36967419

RÉSUMÉ

Hematopoietic stem cell transplantation (HSCT) represents a curative option for pediatric patients affected by malignant and non-malignant disorders. Several complications may arise during the post-transplantation period, including immune-mediated disorders. Immune-mediated cytopenias (IMCs) account for up to 22% of pediatric HSCT complications, representing an important cause of morbidity and mortality post-HSCT. So far, their pathogenesis is not well-understood, and their management may be very challenging. Further, most patients are refractory to first-line treatment which is based on high-dose intravenous steroids, immunoglobulin, and the monoclonal anti-CD20 antibody - rituximab. No clear consensus has been reached for second- and third-line therapeutic options. CONCLUSION: We reviewed the epidemiology, risk factors, pathogenesis, and treatment of IMCs, aiming to offer a deeper understanding of these complications as a guide to improving the management of these fragile patients and a cue for the design of tailored clinical trials. WHAT IS KNOWN: • IMCs arising in the post-HSCT setting represent a rare but potentially life-threatening complication. Younger patients affected by non-malignant disorders are at the greatest risk of IMCs arising after HSCT. Corticosteroids, intravenous immunoglobulin, and rituximab represent the undiscussed first-line therapeutic approach. WHAT IS NEW: • This review highlitghts how children present unique risk factors for post HSCT IMCs, which are the result of the complex relationship between the immaturity of their infantile immune system and all the perturbing agents and factors which characterize the post-HSCT setting. Future efforts are warranted to establish the best option for refractory patients, for whom a standard and validated approach is not currently available. Among new agents, ibrutinib or bortezomib and fostamatinib or low-dose IL-2 could represent a good therapeutic option for patients with graft-versus-host disease and hemolytic anemia or graft-versus-host disease and thrombocytopenia, respectively.


Sujet(s)
Maladie du greffon contre l'hôte , Transplantation de cellules souches hématopoïétiques , Thrombopénie , Humains , Enfant , Rituximab/usage thérapeutique , Transplantation de cellules souches hématopoïétiques/effets indésirables , Maladie du greffon contre l'hôte/épidémiologie , Maladie du greffon contre l'hôte/étiologie , Maladie du greffon contre l'hôte/thérapie , Thrombopénie/étiologie , Facteurs de risque
4.
Int J Mol Sci ; 23(6)2022 Mar 17.
Article de Anglais | MEDLINE | ID: mdl-35328655

RÉSUMÉ

Mesenchymal stem cells (MSCs) are classified as advanced therapy medicinal products, a new category of GMP (good manufacturing practice)-compliant medicines for clinical use. We isolated MSCs from 5 bone marrow (BM) samples using human platelet lysate (HPL) instead of foetal bovine serum (FBS). We used a new method of HPL production consisting of treating platelet (PLTs) pools with Ca-Gluconate to form a gel clot, then mechanically squeezing to release growth factors. We compared the new HPL (HPL-S) with the standard (HPL-E) obtained by freezing/thawing cycles and by adding heparin. HPL-S had not PLTs and fibrinogen but the quantity of proteins and growth factors was comparable to HPL-E. Therefore, HPL-S needed fewer production steps to be in compliance with GMP conditions. The number of colonies forming unit-fibroblasts (CFU-F) and the maintenance of stem markers showed no significant differences between MSCs with HPL-E and HPL-S. The cumulative population doubling was higher in MSCs with HPL-E in the earlier passages, but we observed an inverted trend of cell growth at the fourth passage. Immunophenotypic analysis showed a significant lower expression of HLA-DR in the MSCs with HPL-S (1.30%) than HPL-E (14.10%). In conclusion, we demonstrated that HPL-S is an effective alternative for MSC production under GMP conditions.


Sujet(s)
Cellules souches mésenchymateuses , Plaquettes/métabolisme , Différenciation cellulaire , Prolifération cellulaire , Cellules cultivées , Milieux de culture/métabolisme , Humains , Immunophénotypage , Protéines et peptides de signalisation intercellulaire/métabolisme , Cellules souches mésenchymateuses/métabolisme
5.
Ital J Pediatr ; 48(1): 13, 2022 Jan 24.
Article de Anglais | MEDLINE | ID: mdl-35073953

RÉSUMÉ

BACKGORUND: Parents after Neonatal Intensive Care Unit (NICU) hospitalization of preterm infant may develop psychopathological symptoms. The aim of the study was to determine how parental stress and psychophysical wellbeing affect posttraumatic symptoms (PTTS) in parents during the first year after NICU discharge. Moreover, this study aimed to explore any gender-specific difference in psychological distress among mothers and fathers. METHODS: Prospective study design from September 2018 to September 2019. 20 pairs of parents of preterm infants admitted to a tertiary-level NICU were enrolled. Primary outcome was evaluation of PTTS in parents of preterm infants at one year after NICU discharge through Impact of Event Scale- Revised. Secondary outcomes were: impact of parental stress, psychophysical wellbeing, anxiety and depression respectively through Parental Stressor Scale: NICU, Short Form Health Survey-36(SF-36), Self-rating Anxiety Scale and Self-rating Depression Scale. RESULTS: Mothers experienced higher rates of PTTS than fathers across the first year after NICU discharge (55% vs 20%). Maternal avoidance symptoms were associated with perception of their own infant look. Emotional aspects linked to maternal role predicted 36,8% of their hyperarousal symptoms. Maternal PTTS severity was predicted by their social functioning. Paternal mental health was associated both with maternal and paternal intrusive symptoms.. Maternal stress was associated with paternal avoidance symptoms. Paternal mental health predicted their hyperarousal symptoms (40%) and PTSD severity (52%). CONCLUSIONS: Parents who experienced NICU hospitalization of their own infant are at heightened risk to develop psychopathological symptoms. According to our initial hypothesis, investigating parental psychophysical wellbeing, through SF-36, originally provides a valuable support to detect parents at higher risk to develop posttraumatic outcomes across the first year after NICU discharge. In addition, paternal depression deserves to be taken into account since hospitalization as it could impact paternal PTSD development. Finally, these findings provide an initial evidence of gender-related patterns in PTSD development and psychological distress among mothers and fathers across the first year of their infant.


Sujet(s)
Unités de soins intensifs néonatals , Détresse psychologique , Pères , Femelle , Humains , Nourrisson , Nouveau-né , Prématuré , Mâle , Mères , Parents , Sortie du patient , Études prospectives , Stress psychologique/diagnostic , Stress psychologique/épidémiologie
6.
MethodsX ; 9: 101603, 2022.
Article de Anglais | MEDLINE | ID: mdl-34976752

RÉSUMÉ

Microplastic pollution has become one of the most pressing environmental issues. A fundamental criterion for risk assessment is the concentration of found microplastic that can be altered during microplastic isolating from the sample. Recovery rate (i.e. positive control) is an important feedback component that identifies accuracy, quality and efficiency of sample processing, same as physical and chemical impact. Here, using 100 µm red polystyrene (PS) beads we have tested some methodological steps that can be responsible for the possible microplastic losses during sample treatment and based on that, we provided a recovery rate threshold values. Our results support that the choice of the extraction method (vacuum filtration versus wet sieving) results in lower recoverability when vacuum filtration is used and that used separatory funnels size versus material amount impacts the efficiency or recoverability in density separation. We have also analysed microplastic recovery rate when different samples treatment steps from widely used isolation protocols (sediment and water) were applied and our results suggest that there are a number of factors affecting recovery rates, of which physical effects (loss by consecutive treatment steps due to material transfer) are more important than possible chemical degradation.•Sample filtration method determines recovery rate from < 40 to > 80%.•The number of sample processing steps involving transfer has a direct impact on recovery rate.•As a measure of quality assurance, recovery rate thresholds are introduced.

7.
Pediatr Transplant ; 26(4): e14233, 2022 06.
Article de Anglais | MEDLINE | ID: mdl-35092128

RÉSUMÉ

BACKGROUND: Allogeneic hematopoietic stem cell transplantation (HSCT) from an unrelated HLA-mismatched donor (MMUD) is one of the alternatives where an HLA-matched donor is not found. The aim of this study was to compare bone marrow (BM) versus peripheral blood stem cells (PBSC) as hematopoietic rescue following allogeneic unrelated mismatched stem cell transplantation (MMUD). METHODS: The patients were divided into two groups: 43 pediatric patients were treated with BM and 17 pediatric patients with PBSC. The study was registered at ClinicalTrials.gov NCT04598789. RESULTS: The 3-year Overall Survival (OS) was 74% versus 31% (p = .0011). Transplant related mortality (TRM) was 16% versus 33% (p = .025), and relapse incidence (RI) was 16% versus 35% (p = .005). The day-100 acute Graft-versus-host disease (GvHD) incidence grade II-IV and III-IV was 30% versus 28% (p = NS) and 17% versus 17% (p = NS). The 3-year chronic GvHD incidence was 22% versus 33% (p = NS). CONCLUSION: Despite all the limits of this retrospective study we were able to show how the combination of BM and ATG is able to prevent GvHDs and guarantee a high OS. Future studies addressing the issue of a post-transplant cellular therapy approach may potentially reduce relapses when GvHD is absent.


Sujet(s)
Maladie du greffon contre l'hôte , Transplantation de cellules souches hématopoïétiques , Cellules souches du sang périphérique , Moelle osseuse , Enfant , Maladie du greffon contre l'hôte/étiologie , Maladie du greffon contre l'hôte/prévention et contrôle , Transplantation de cellules souches hématopoïétiques/effets indésirables , Humains , Récidive tumorale locale/étiologie , Études rétrospectives , Donneurs non apparentés
8.
Mar Pollut Bull ; 172: 112860, 2021 Nov.
Article de Anglais | MEDLINE | ID: mdl-34455347

RÉSUMÉ

The study is comparing microplastic debris distribution and composition in the Gulf of Riga and the Eastern Gotland Basin, Baltic Sea. Samples from 44 stations were collected from coastal and open water sites using Manta trawl (mesh size 300 µm). The natural organic material was digested sequentially with sodium hydroxide, hydrogen peroxide and enzymes. Thereafter, micro-debris (16,315 particles) was identified by visual analysis and 5285 particles were analyzed with Attenuated Total Reflection Fourier Transform Infrared spectroscopy method. The abundance of particles varied from 0.09 to 4.43 particles per m-3. The fibers accounted for 66.1% of all encountered particles while the fragments for 30.2%. The predominant polymer types were polyethylene (77.9%) and polypropylene (11.1%). The relative proportion among polymer types varied considerably from station to station. The encountered concentrations of micro-debris were well in range of values reported from other regions of the Baltic Sea.


Sujet(s)
Microplastiques , Polluants chimiques de l'eau , Surveillance de l'environnement , Matières plastiques , Polyéthylène , Polluants chimiques de l'eau/analyse
SÉLECTION CITATIONS
DÉTAIL DE RECHERCHE
...